STEADY-STATE BIOAVAILABILITY OF 2 CLORAZEPATE DIPOTASSIUM DOSAGE FORMS

被引：16

作者：

CARRIGAN, PJ ^{[1
]}

CHAO, GC ^{[1
]}

BARKER, WM ^{[1
]}

HOFFMAN, DJ ^{[1
]}

CHUN, AHC ^{[1
]}

机构：

[1] ABBOTT LABS,DIV PHARM PROD,N CHICAGO,IL 60064

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1977年 / 17卷 / 01期

关键词：

D O I：

10.1002/j.1552-4604.1977.tb04582.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：18 / 28

页数：11

共 10 条

[1] EFFECTS OF DIFFERENT RATES OF ABSORPTION OF 2 BENZODIAZEPINS ON SUBJECTIVE AND OBJECTIVE PARAMETERS - SIGNIFICANCE FOR CLINICAL USE AND RISK OF ABUSE [J].

BLIDING, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (03) :201-211

[2] CLORAZEPATE DIPOTASSIUM IN TREATMENT OF INTRACTABLE EPILEPSY [J].

BOOKER, HE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 229 (05) :552-555

[3]

CHAO GC, 1975, BIOMETRICS, V31, P1001

[4]

GHONEIM MM, 1975, ANESTH ANALG, V54, P173

[5]

GIBALDI M, 1975, PHARMACOKINETICS, P80

[6]

HILLESTA.L, 1974, CLIN PHARMACOL THER, V16, P485

[7] GLC DETERMINATION OF PLASMA DRUG LEVELS AFTER ORAL-ADMINISTRATION OF CLORAZEPATE POTASSIUM SALTS [J].

HOFFMAN, DJ ;

CHUN, AHC .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (10) :1668-1671

[8] PHARMACOKINETIC PROFILE OF DIAZEPAM IN MAN FOLLOWING SINGLE INTRAVENOUS AND ORAL AND CHRONIC ORAL ADMINISTRATIONS [J].

KAPLAN, SA ;

JACK, ML ;

ALEXANDER, K ;

WEINFELD, RE .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (11) :1789-1796

[9]

METZLER CM, 1969, 7292697292005 TECHN

[10]

WAGNER JG, 1971, BIOPHARMACEUTICS REL, P293

← 1 →